What is the role of noninvasive ventilation (NIV) in the treatment of immunocompromised patients?

Updated: Jun 18, 2020
  • Author: Guy W Soo Hoo, MD, MPH; Chief Editor: Zab Mosenifar, MD, FACP, FCCP  more...
  • Print


In immunocompromised patients and hypoxemic respiratory failure, note the following:

  • Solid organ transplantation [58]  - Single-center trial, approximately 50 patients; subgroup with cardiogenic pulmonary edema fared best

  • Febrile neutropenic patients - Single-center trial, approximately 50 patients; mostly hematologic malignancies or bone marrow transplantations; benefit of noninvasive ventilation in those with an identified cause of pneumonia; severity of illness relatively modest

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!